BSEM
Price:
$4.13
Market Cap:
$68.83M
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The c...[Read more]
Industry
Biotechnology
IPO Date
2015-03-17
Stock Exchange
OTC
Ticker
BSEM
According to BioStem Technologies, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 2.81. This represents a change of -115.43% compared to the average of -18.21 of the last 4 quarters.
The mean historical PE Ratio of BioStem Technologies, Inc. over the last ten years is -5.77. The current 2.81 PE Ratio has changed -4974.16% with respect to the historical average. Over the past ten years (40 quarters), BSEM's PE Ratio was at its highest in in the June 2022 quarter at 31.45. The PE Ratio was at its lowest in in the June 2025 quarter at -95.11.
Average
-5.77
Median
-6.27
Minimum
-13.10
Maximum
7.11
Discovering the peaks and valleys of BioStem Technologies, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 96.44%
Maximum Annual PE Ratio = 7.11
Minimum Annual Increase = -175.04%
Minimum Annual PE Ratio = -13.10
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 7.11 | -175.04% |
| 2023 | -9.47 | 96.44% |
| 2022 | -4.82 | -42.67% |
| 2021 | -8.41 | 50.96% |
| 2020 | -5.57 | 53.71% |
| 2019 | -3.62 | 6.09% |
| 2018 | -3.42 | -73.92% |
| 2017 | -13.10 | 39.50% |
| 2016 | -9.39 | 34.77% |
| 2015 | -6.97 | -59.13% |
The current PE Ratio of BioStem Technologies, Inc. (BSEM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.39
5-year avg
-4.23
10-year avg
-5.77
BioStem Technologies, Inc.’s PE Ratio is greater than IXICO plc (-6.39), greater than Nicox S.A. (-0.68), greater than Alterity Therapeutics Limited (-4.93), greater than Satellos Bioscience Inc. (-1.76), greater than Calliditas Therapeutics AB (publ) (-23.95), greater than Actinogen Medical Limited (-11.77), greater than MedX Health Corp (-0.86), greater than Imugene Limited (-1.02), greater than ZIVO Bioscience, Inc. (-4.50), greater than Vicapsys Life Sciences, Inc. (-62.85),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.39 | $6.49M | |
| -0.68 | $35.57M | |
| -4.93 | $68.52M | |
| -1.76 | $87.00M | |
| -23.95 | $36.83M | |
| -11.77 | $127.29M | |
| -0.86 | $11.84M | |
| -1.02 | $57.72M | |
| -4.50 | $38.89M | |
| -62.85 | $48.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioStem Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioStem Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioStem Technologies, Inc.'s PE Ratio?
How is the PE Ratio calculated for BioStem Technologies, Inc. (BSEM)?
What is the highest PE Ratio for BioStem Technologies, Inc. (BSEM)?
What is the 3-year average PE Ratio for BioStem Technologies, Inc. (BSEM)?
What is the 5-year average PE Ratio for BioStem Technologies, Inc. (BSEM)?
How does the current PE Ratio for BioStem Technologies, Inc. (BSEM) compare to its historical average?